15 May 2024 PYC Therapeutics: GLP TOX RESULTS CLEAR PATH FOR SECOND BLINDING EYE DISEASE DRUG TO ENTER HUMAN TRIALS 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post